Up-regulation of transgelin-2 was observed in pancreatic cancer [8], colorectal cancer [9], lung adenocarcinoma [10, 11] and cervical squamous cell carcinoma [12]. Here, TAGLN2 is linked to familial pancreatic carcinoma.